Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Merck & Co. Inc.

www.merck.com

Latest From Novartis Pharmaceuticals UK Ltd.

Latest Entrant To UK Early Access Scheme Is AstraZeneca's Osimertinib

Lung cancer drug, recently approved in the US as Tagrisso, is fourth product made available early to UK patients as it awaits EU marketing approval.

BioPharmaceutical United Kingdom

Asia On The Move: Personnel News From China FDA, Takeda, SciClone And WuXiPRA

China FDA appoints new deputy commissioner, Takeda names new directors, SciClone hires CFO with an emphasis on compliance, and personnel news from WuxiPRA, Cipla and RDPAC.

BioPharmaceutical China

Deals Shaping the Medical Industry (11/06)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions database, providing comprehensive transaction coverage from 1991 to the present.

Recent Dealmaking (11/2003)

Summarizing the month in European dealmaking.
See All

Company Information

Advertisement
Advertisement
UsernamePublicRestriction

Register